مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

598
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

392
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

1

Information Journal Paper

Title

ECONOMIC BURDEN OF HEPATITIS B VIRUS-RELATED DISEASES: EVIDENCE FROM IRAN

Pages

  0-0

Abstract

 Background: Hepatitis B infection is still the main cause of chronic liver disease in Iran, which is associated with significant economic and social costs.Objectives: This study aimed to estimate the financial burden caused by CHB infection and its complications in Iran.Patients and Methods: Prevalence-based and bottom-up approaches were used to collect the data. Data on direct medical costs were extracted from outpatient medical records in a referral gastroenterology and hepatology research center, inpatient medical records in several major hospitals in Tehran and Shiraz in 2013, and the self-reports of specialists. Data on direct non-medical and indirect costs were collected based on the patients’ self-reports through face-to-face interviews performed in the mentioned centers. To calculate the indirect costs, friction cost approach was used. To calculate the total cost-of-illness in Iran, the total cost per patient at each stage of the disease was estimated and multiplied by the total number of patients.Results: The total annual cost for the activate population of CHB patients and for those receiving treatment at various disease stages were respectively 450 million and 226 million dollars, with 64% and 70% of which allocated to direct costs respectively, and 36% and 30% to indirect costs respectively. The total direct costs alone for each group were respectively 1.17% and 0.6% of the total health expenditure. Furthermore, the cost spent on drugs encompasses the largest proportion of the direct medical cost for all stages of the disease.Conclusions: According to the perspectives of payers, patients, and community, CHB infection can be considered as one of the DISEASES with a substantial economic burden; the disease, specifically in extreme cases, can be too expensive and costly for patients. Therefore, patients should be protected against more severe stages of the disease through proper treatment and early diagnosis.

Cites

References

Cite

APA: Copy

KESHAVARZ, KHOSRO, KEBRIAEEZADEH, ABBAS, ALAVIAN, SEYED MOAYED, AKBARI SARI, ALI, ABEDIN DORKOOSH, FARID, KESHVARI, MARYAM, MALEKHOSSEINI, SEYED ALI, NIKEGHBALIAN, SAMAN, & NIKFAR, SHEKOUFEH. (2015). ECONOMIC BURDEN OF HEPATITIS B VIRUS-RELATED DISEASES: EVIDENCE FROM IRAN. HEPATITIS MONTHLY, 15(4), 0-0. SID. https://sid.ir/paper/306905/en

Vancouver: Copy

KESHAVARZ KHOSRO, KEBRIAEEZADEH ABBAS, ALAVIAN SEYED MOAYED, AKBARI SARI ALI, ABEDIN DORKOOSH FARID, KESHVARI MARYAM, MALEKHOSSEINI SEYED ALI, NIKEGHBALIAN SAMAN, NIKFAR SHEKOUFEH. ECONOMIC BURDEN OF HEPATITIS B VIRUS-RELATED DISEASES: EVIDENCE FROM IRAN. HEPATITIS MONTHLY[Internet]. 2015;15(4):0-0. Available from: https://sid.ir/paper/306905/en

IEEE: Copy

KHOSRO KESHAVARZ, ABBAS KEBRIAEEZADEH, SEYED MOAYED ALAVIAN, ALI AKBARI SARI, FARID ABEDIN DORKOOSH, MARYAM KESHVARI, SEYED ALI MALEKHOSSEINI, SAMAN NIKEGHBALIAN, and SHEKOUFEH NIKFAR, “ECONOMIC BURDEN OF HEPATITIS B VIRUS-RELATED DISEASES: EVIDENCE FROM IRAN,” HEPATITIS MONTHLY, vol. 15, no. 4, pp. 0–0, 2015, [Online]. Available: https://sid.ir/paper/306905/en

Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button